Alliance Creative Group (ACGX) Reports Total Revenue of $2,308,725 for Third Quarter of 2020 with Gross Profit of $660,341.

News, market analysis, investment scam prevention tips and more ✔️ Your source for latest asset management news and information. This magazine is crafted specifically for those who are interested in diving into the global asset management world. CHICAGO, Nov. 23, 2020 /PRNewswire/ -- Alliance Creative Group, Inc., (https://www.AllianceCreativeGroup.com) (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Three Months Ending September 30, 2020. To keep reading about Alliance Creative Group (ACGX) Reports Total Revenue of $2,308,725 for Third Quarter of 2020 with Gross Profit of $660,341., Click on the link. Seoul, Korea
http://dlvr.it/RmGrPp

Comments

Post a Comment

Popular posts from this blog

Stock Alert: Moderna Jumps 16% As Covid Vaccine 94.1% Effective; To Apply For Emergency Use

Image
Financial world news, market analysis, investment scam prevention tips and more ✔️ Learn all there is to know about the asset management industry. This magazine is crafted specifically for those who are interested in diving into the global asset management world. (RTTNews) - Shares of Moderna, Inc. (MRNA) are rising more than 16% Monday morning after the company said it is planning to apply for U.S and European Emergency approval of its Covid-19 vaccine mRNA-1273, as its late study showed that the vaccine candidate is 94.1% effective to prevent the disease. The stock touched a new high of $150 this morning The company on Monday said it plans to apply for Emergency Use Authorization (EUA) from the U.S. FDA and conditional approval from the European Medicines Agency (EMA). The company also reported vaccine efficacy against severe Covid-19 was 100%. To keep reading about Stock Alert: Moderna Jumps 16% As Covid Vaccine 94.1% Effective; To Apply For Emergency Use, Click on the link. Seo...
Read more

Indonesia approves China's Sinovac vaccine as infections surge

Image
News, market analysis, investment scam prevention tips and more ✔️ Your source for latest asset management news and information. This magazine is crafted specifically for those who are interested in diving into the global asset management world. Indonesia gave Sinovac Biotech's Covid-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths. To keep reading about Indonesia approves China's Sinovac vaccine as infections surge, Click on the link. Seoul, Korea http://dlvr.it/RqLHMP
Read more